FDA inspection
Lupin Limited (Biotech Division): FDA inspection ending Oct 14, 2022
FDA inspection 1190385 · Official Action Indicated (OAI) · Pune
Key facts
| Inspection ID | 1190385 |
|---|---|
| Firm | Lupin Limited (Biotech Division) |
| FEI number | 3010977634 |
| Address | 1157 1158 1159 & 1160 Gat No 1156 |
| City | Pune |
| Fiscal year | 2023 |
| Inspection end date | Oct 14, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data